Pancreatic Cancer Research

ResearcherInsermActive in the last 2 years

Christelle d’Engremont

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5061394122. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
40
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 7

  1. Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer. Co-author DOI 10.1038/s41586-026-10436-4↗
  2. Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective obs… Co-author DOI 10.1016/j.ejca.2022.01.040↗
  3. Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.683289↗
  4. Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitors. Co-author DOI 10.1177/1758835920937949↗
  5. FOLFOXIRI vs FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study. Co-author DOI 10.4251/wjgo.v12.i3.332↗
  6. Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma. Co-author DOI 10.1093/jnci/djx037↗
  7. Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a mu… Co-author DOI 10.1186/s12885-016-2860-6↗

Closest collaborators

The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anthony Turpin · 4 shared papers, 2020–2026 · strength 0.50
  2. Christophe Borg · 5 shared papers, 2016–2022 · strength 0.42
  3. Olivier Bouché · 3 shared papers, 2017–2026 · strength 0.36
  4. Déwi Vernerey · 4 shared papers, 2016–2021 · strength 0.31
  5. Gaël S. Roth · 2 shared papers, 2022–2026 · strength 0.31
  6. Camille Evrard · 2 shared papers, 2022–2026 · strength 0.31
  7. Nicolas Williet · 2 shared papers, 2022–2026 · strength 0.31
  8. Angélique Vienot · 3 shared papers, 2017–2021 · strength 0.26
  9. Mircea Chirica · 1 shared paper, 2026 · strength 0.20
  10. Pauline Parent · 1 shared paper, 2026 · strength 0.20
  11. Jean‐Frédéric Blanc · 1 shared paper, 2026 · strength 0.20
  12. Jerome F. Cros · 1 shared paper, 2026 · strength 0.20
  13. Jean‐Yves Scoazec · 1 shared paper, 2026 · strength 0.20
  14. Patrick Mehlen · 1 shared paper, 2026 · strength 0.20
  15. Astrid Lièvre · 1 shared paper, 2026 · strength 0.20
  16. Jean‐Baptiste Bachet · 1 shared paper, 2026 · strength 0.20
  17. Cindy Neuzillet · 2 shared papers, 2017–2020 · strength 0.16
  18. Louis de Mestier · 2 shared papers, 2017–2020 · strength 0.16
  19. Frédéric Di Fiore · 1 shared paper, 2022 · strength 0.11
  20. Tullio Piardi · 1 shared paper, 2022 · strength 0.11
  21. Lilian Schwarz · 1 shared paper, 2022 · strength 0.11
  22. Mathias Brügel · 1 shared paper, 2022 · strength 0.11
  23. Mehdi El Amrani · 1 shared paper, 2022 · strength 0.11
  24. Stéphanie Truant · 1 shared paper, 2022 · strength 0.11
  25. Alexandre Doussot · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.